SEARCH

LEGAL UPDATE

Another US patent litigation win for Orexo AB’s ZUBSOLV®

On 30 June 2023 the US District Court for the District of New Jersey ruled in favour of Orexo AB in its patent litigation against Sun in relation to ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), with the Court ruling that Orexo’s patents are both valid and are infringed by Sun.

UP & UPC

UPC revocation actions offer an attractive patent strategy

This article touches on our experience so far in handling revocation actions for clients before the UPC. The article also comments on some of the strategic and commercial considerations relevant when deciding on whether to pursue UPC revocation proceedings.

LEGAL UPDATE

What are the IP ownership options?

When it comes to intellectual property (IP) ownership, a business has several options. Choosing the best option will depend on the nature of the IP, your commercial objectives and the associated legal obligations.